
Synopsys shares surged 21.78% in the past month following a tough period in late 2025, driven by strong demand for AI-driven chip design and integration of Ansys, which expanded its market by 63%. The company reported Q1 FY26 revenue of $2.41 billion, beating estimates, and significantly improved operating cash flow while reducing long-term debt. Analysts are optimistic with a $608.97 price target, implying nearly 20% upside, supported by solid forward earnings and cash flow visibility. Risks include high valuation, exposure to China amid export controls, and potential margin pressures, but the overall outlook remains positive if growth and integration continue as planned.